Major Japanese technology firm NEC Corporation has expanded its presence in the pharmaceutical industry in Europe, establishing two additional operations in the biopharmaceutical sector at the end of March. NEC Bio B.V. (NB) in Hilversum, the Netherlands and NEC Bio Therapeutics (NBT) in Mannheim, Germany have joined its other healthcare tech-related subsidiaries.
Japan's NEC Expands Biopharma Presence With AI-Based R&D
Now in Norway, Netherlands and Germany
Japanese tech major re-structures its teams for artificial intelligence-based drug development and strategies while expanding its presence in Europe. With confidence in the utility of AI for discovery, it is retaining a key focus on oncology while adding infectious diseases to its targets.
